You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Parkinson Disease,

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Primary Effusion Trial run by the National Cancer Institute (NCI) (Daratumumab SC)

Not yet recruiting
  • Lymphoma, Primary Effusion
  • Daratumumab SC
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 23, 2023

Natural History Study of Oculopharyngeal Muscular Dystrophy

Withdrawn
  • Oculopharyngeal Muscular Dystrophy
  • Non-interventional study
  • (no location specified)
May 23, 2022

Periodontitis, Airway Obstruction, Lung Inflammation Trial in Bergen (Periodontal treatment)

Enrolling by invitation
  • Periodontitis
  • +2 more
  • Periodontal treatment
  • Bergen, Norway
    Department of Clinical Dentistry, University of Bergen
Jul 13, 2022

Fibrodysplasia Ossificans Progressiva Trial

Not yet recruiting
  • Fibrodysplasia Ossificans Progressiva
    • (no location specified)
    Oct 13, 2023

    HFI Trial in Maastricht (PF-06801591)

    Recruiting
    • HFI
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical centre
    Oct 16, 2023

    Cutaneous Diphtheria in France : Observational, Retrospective

    Not yet recruiting
    • Corynebacterium Diphtheriae Infection
    • Characteristics description
    • Toulon, VAR, France
      HIA Sainte Anne
    Apr 3, 2023

    Probiotics Trial in Bolzano (Probiotic administration and gluten, Placebo administration and gluten)

    Completed
    • Probiotics
    • Probiotic administration and gluten
    • Placebo administration and gluten
    • Bolzano, Italy
      Free University of Bolzano-Bozen
    Mar 22, 2023

    Cardiac Sarcoidosis Trial (PET/MRI)

    Not yet recruiting
    • Cardiac Sarcoidosis
    • PET/MRI
    • (no location specified)
    Jul 26, 2023

    Diabetes, Type 1, Diabetes, Type 2, Diabetes, Youth Onset Trial (PI-2620 tracer)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • +2 more
    • PI-2620 tracer
    • (no location specified)
    Apr 21, 2022

    Survival Analysis in Children and Adults Adrenocortical Cancer

    Active, not recruiting
    • Adrenocortical Carcinoma
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Jan 20, 2023

      Crohn's Disease (CD) Trial in Worldwide (Risankizumab, Ustekinumab)

      Recruiting
      • Crohn's Disease (CD)
      • Chandler, Arizona
      • +298 more
      Aug 16, 2022

      Chronic Kidney Diseases, Chronic Disease, Chronic Kidney Disease, Stage 3 (Moderate) Trial in United States (Control-EDI,

      Recruiting
      • Chronic Kidney Diseases
      • +4 more
      • Control-EDI
      • Intervention-EDI and health coaching
      • Ann Arbor, Michigan
      • +10 more
      Aug 30, 2022

      Peripheral Artery Disease Trial (Leg heat therapy, Sham Control)

      Not yet recruiting
      • Peripheral Artery Disease
      • Leg heat therapy
      • Sham Control
      • (no location specified)
      Jul 15, 2022

      Prevalence of Renal Disease in Children With Celiac Disease

      Not yet recruiting
      • Celiac Disease
      • urine sample taken during consultations
      • Paris, France
        Robert Debre Hospital
      Oct 1, 2021

      iMmune SignAtures and Clinical outComes in AP

      Recruiting
      • Acute Pancreatitis
      • CyTOF Analysis
      • Los Angeles, California
      • +4 more
      May 17, 2023

      Healthcare Disparities in Alopecia Areata

      Active, not recruiting
      • Alopecia Areata
      • No intervention
      • London, United Kingdom
        Momentum Data Limited
      Feb 3, 2023

      Cohort of Twin Pregnancy and the Offspring

      Not yet recruiting
      • Twin Pregnancy
      • All pregnant women with a twin pregnancy and the offspring
      • Shanghai, Shanghai, China
        Obstetrics and Gynecology Hospital of Fudan University
      Feb 13, 2023

      COVID-19 Trial in Jena (Infliximab, Standard of Care)

      Recruiting
      • COVID-19
      • Jena, Germany
        Jena University Hospital
      Aug 10, 2022

      Hypertension, Portal Trial in Philadelphia (SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane

      Recruiting
      • Hypertension, Portal
      • SHAPE measurement using the ultrasound contrast agent Sonazoid (perfluorobutane microbubbles)
      • SHAPE measurement using the ultrasound contrast agent Lumason (sulfur hexafluoride lipid-type A microspheres)
      • Philadelphia, Pennsylvania
        The Children's Hospital of Philadelphia
      Jan 20, 2022

      Insights Into Microbiome and Environmental Contributions to

      Recruiting
      • Genetic Disease
      • Genomics
        • Bethesda, Maryland
        • +3 more
        Apr 7, 2022

        ASCVD, Coronary Artery Calcification Trial (Notification of patients and clinicians)

        Not yet recruiting
        • ASCVD
        • Coronary Artery Calcification
        • Notification of patients and clinicians
        • (no location specified)
        May 5, 2023

        Amyotrophic Lateral Sclerosis Trial in Italy (Colchicine 1 MG Oral Tablet, Placebo Oral Tablet)

        Active, not recruiting
        • Amyotrophic Lateral Sclerosis
        • Colchicine 1 MG Oral Tablet
        • Placebo Oral Tablet
        • Bari, Italy
        • +9 more
        Aug 9, 2022

        Baseline Vitamin D Deficiency and COVID-19 Disease Severity

        Completed
        • Vitamin D Deficiency
        • Covid19
        • Vitamin D
        • Pueblo, Colorado
          Parkview Medical Center
        Sep 30, 2022

        3T MR for Secondary Hyperparathyroidism Comparison With 4DCT

        Not yet recruiting
        • Parathyroid Gland Disease
        • Secondary Hyperparathyroidism
          • (no location specified)
          Sep 15, 2022

          Small Cell Lung Carcinoma Trial in Denmark, Norway, Sweden (45 Gy in 30 fractions, 60 Gy in 40 fractions)

          Active, not recruiting
          • Small Cell Lung Carcinoma
          • 45 Gy in 30 fractions
          • 60 Gy in 40 fractions
          • København, Denmark
          • +21 more
          Sep 16, 2022